Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Original Article

Volume 9, Number 1-2, April 2020, pages 5-8

Management of Iron-Deficiency Anemia on Inpatients and Appropriate Discharge and Follow-Up

Tables

Table 1. Demographics (N = 103)
 
VariablesN (%) or result
Gender, N (%)
  Male28 (27%)
  Female75 (72.8%)
Race, N (%)
  Caucasian41 (39.8%)
  African American39 (37.9%)
  Latino9 (8.7%)
  Asian6 (5.8%)
  Other8 (7.8%)
Age (average, years)
  Male68.0
  Female60.6

 

Table 2. Inpatient Iron Supplementation and Discharge
 
Inpatient iron supplementation and dischargeN (%)
Any form of iron supplementation inpatient62 (60.2%)
Oral ferrous sulfate inpatient21 (20.4%)
Intravenous iron sucrose inpatient33 (32%)
Intravenous sodium ferric gluconate inpatient8 (7.8%)
Oral iron supplementation on discharge53/103 (51.5%)
Appropriate follow-up with primary care physician, hematologist, gastroenterologist, or obstetric gynecologist on discharge paperwork or discharged on oral iron supplementation54 (52.4%)
Proper documentation of iron-deficiency anemia on discharge paperwork50 (48%)

 

Table 3. Appropriate Documentation of Iron-Deficiency Anemia and Having EGD/Colonoscopy, Blood transfusion, and Symptomatic Anemia
 
VariablesN (%)P value (Chi-square)Relative risk (95% CI)Odds ratio
EGD: esophagogastroduodenoscopy; 95% CI: 95% confidence interval.
Procedure and appropriate discharge documentation< 0.001 (17.1)2.3 (1.7 - 3.2)14.3
  Yes18/20 (90%)
  No32/83 (38.6%)
Blood transfusion and appropriate discharge documentation0.0012 (10.6)1.93 (1.3 - 2.9)2.07
  Yes29/43 (67.4%)
  No21/60 (35%)
Diagnostic criteria and appropriate discharge documentation< 0.001 (16.8)2.56 (1.5 - 4.3)5.67
  Yes38/57 (66.7%)
  No12/46 (26.1%)